TrialPain medicine (Malden, Mass.)2018

A Randomized, Double-Blind, Placebo- and Active Comparator-Controlled Phase I Study of Analgesic/Antihyperalgesic Properties of ASP8477, a Fatty Acid Amide Hydrolase Inhibitor, in Healthy Female Subjects.

Klaus Schaffler et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.